» Articles » PMID: 35130627

The Functions of CD4 T-helper Lymphocytes in Chronic Obstructive Pulmonary Disease

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic obstructive pulmonary disease (COPD) has been increasingly accounted for global morbidity and mortality worldwide. Although it is partially reversible, the obstructive ventilatory schema of COPD often causes chronic inflammation that primarily affects peripheral airways, pulmonary parenchyma, and the development of lung lymphoid follicles. Among various T-helper (Th) cell types associated with COPD, Th1, Th2 and Th17 cell numbers are increased in COPD patients, whereas Treg cell number is reduced. Here, we reviewed recent advance in understanding the roles of Th1/Th2 and Th17/Treg in the pathogenesis of COPD and discussed the potential underlying mechanism.

Citing Articles

The standardization and efficacy of fermented (L.) in combination with enrofloxacin against artificially induced pneumonic pasteurellosis in rat models.

Prakoso Y, Susilo A, Widyarini S Open Vet J. 2025; 14(12):3404-3416.

PMID: 39927353 PMC: 11799618. DOI: 10.5455/OVJ.2024.v14.i12.25.


NFIL3/Tim3 axis regulates effector Th1 inflammation in COPD mice.

Ke J, Huang S, He Z, Lei S, Lin S, Li Y Front Immunol. 2024; 15:1482213.

PMID: 39555065 PMC: 11563780. DOI: 10.3389/fimmu.2024.1482213.


Effects of fermented L. on the profile of hematology, clinical chemistry, and circulatory CD4+/CD8+ in Sprague Dawley rats.

Wijayanti A, Prakoso Y, Isla K Open Vet J. 2024; 14(9):2475-2483.

PMID: 39553756 PMC: 11563629. DOI: 10.5455/OVJ.2024.v14.i9.36.


Differential proteins from EVs identification based on tandem mass tags analysis and effect of Treg-derived EVs on T-lymphocytes in COPD patients.

Tao X, Xu Z, Tian H, He J, Wang G, Tao X Respir Res. 2024; 25(1):349.

PMID: 39342213 PMC: 11439212. DOI: 10.1186/s12931-024-02980-2.


What every clinician should know about inflammation in COPD.

Wechsler M, Wells J ERJ Open Res. 2024; 10(5).

PMID: 39319045 PMC: 11417604. DOI: 10.1183/23120541.00177-2024.


References
1.
Barnes P . Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2016; 138(1):16-27. DOI: 10.1016/j.jaci.2016.05.011. View

2.
Freeman C, Curtis J . Lung Dendritic Cells: Shaping Immune Responses throughout Chronic Obstructive Pulmonary Disease Progression. Am J Respir Cell Mol Biol. 2016; 56(2):152-159. PMC: 6222925. DOI: 10.1165/rcmb.2016-0272TR. View

3.
Freeman C, Curtis J . It's Complicated: Lung Dendritic Cells in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2020; 202(4):479-481. PMC: 7427380. DOI: 10.1164/rccm.202004-0899ED. View

4.
De Grove K, Provoost S, Verhamme F, Bracke K, Joos G, Maes T . Characterization and Quantification of Innate Lymphoid Cell Subsets in Human Lung. PLoS One. 2016; 11(1):e0145961. PMC: 4699688. DOI: 10.1371/journal.pone.0145961. View

5.
Roos A, Sanden C, Mori M, Bjermer L, Stampfli M, Erjefalt J . IL-17A Is Elevated in End-Stage Chronic Obstructive Pulmonary Disease and Contributes to Cigarette Smoke-induced Lymphoid Neogenesis. Am J Respir Crit Care Med. 2015; 191(11):1232-41. DOI: 10.1164/rccm.201410-1861OC. View